RBC Global Asset Management Unveils New ETFs
Canadian investors have something to look forward to as RBC Global Asset Management Inc. (RBC GAM Inc.) rolls out two new ETF series, significantly broadening the investment options for them. The recently launched funds, the RBC U.S. Mid-Cap Growth Equity Fund and the RBC Life Science and Technology Fund, are now listed and actively trading on the Cboe Canada exchange. This strategic move reflects RBC GAM's dedication to catering to the investment needs of both Canadian advisors and their clients.
A Closer Look at the New ETF Series
The RBC U.S. Mid-Cap Growth Equity Fund, trading under the ticker RUMG, is tailored for long-term capital appreciation primarily through investments in mid-capitalized U.S. listed equities. This fund assesses various industries within the U.S. market, meticulously analyzing economic data and company performance to identify growth opportunities. This thoughtful strategy aims to optimize return on investment while encouraging sustainable growth for stakeholders.
Overview of the RBC Life Science and Technology Fund
Another significant launch is the RBC Life Science and Technology Fund, which trades under the ticker RLST. This fund targets long-term capital growth by investing in equity securities from U.S. companies that focus on the life sciences and technology sectors. Concentrating on areas such as biotechnology, pharmaceuticals, internet infrastructure, and telecommunications, this fund is designed to take advantage of industries that are expected to thrive in an era driven by innovation.
Insights from RBC Leadership
Stephen Hoffman, the Managing Director of ETFs at RBC GAM Inc., expressed his enthusiasm about this development, stating, "We are excited to expand our relationship with Cboe Canada with the listing of these two new ETF Series of RBC Funds. By launching these new actively managed ETFs, we are providing Canadian advisors and investors who prefer to invest using ETFs with access to the long-standing investment expertise of RBC GAM’s North American Equity team." This commitment to delivering quality investment options highlights RBC's focus on enhancing the financial landscape for its clients.
The Importance of Cboe Canada
Rob Marrocco, Global Head of ETF Listings at Cboe Global Markets, provided further insights into the significance of these launches. He remarked, "RBC iShare’s latest additions to their product shelf provide both diversified exposure to U.S. markets and new options for those looking to invest in science and technology during an era defined by innovation. We are honoured that RBC iShares has chosen Cboe Canada as the preferred listing venue for their newest ETF series, and we look forward to furthering our partnership as we continue to bring innovative solutions to the Canadian ETF landscape." This partnership underscores the rising importance of the Canadian market and the push for innovation in investment products.
How to Access the New ETFs
These new funds are now available along with a strong lineup of existing RBC GAM ETFs that are already trading on Cboe Canada, giving investors various avenues to diversify their portfolios. Investors can purchase units of all RBC GAM ETFs through reliable investment channels, including discount brokerage platforms and full-service dealers. This accessibility reflects RBC's commitment to ensuring that clients have a seamless investment experience.
About Cboe Canada
Cboe Canada serves as a Tier 1 stock exchange, providing unmatched services and a trustworthy environment for issuers. Established in 2015, it has become a vital platform for investment products, facilitating significant trading volumes of Canadian listed securities. Cboe Canada consistently represents about 15% of all trading activity within the country, showcasing its crucial role in the investment ecosystem.
About RBC Global Asset Management
Part of the Royal Bank of Canada, RBC Global Asset Management (RBC GAM) is renowned for its comprehensive investment services. Managing over $575 billion in assets, RBC GAM caters to a variety of client needs, ranging from individual investors to large institutions. Their expert team, which comprises around 1,500 professionals, ensures that investors receive the guidance and knowledge necessary to achieve their financial aspirations.
Connecting with RBC GAM and Cboe Canada
For investors eager to discover more about these exciting new products and services from RBC GAM and Cboe Canada, visiting their respective platforms will provide detailed information. With a strong emphasis on client satisfaction and resource accessibility, RBC GAM and Cboe Canada continue to innovate and expand their offerings for Canadian investors.
Frequently Asked Questions
What are the new ETFs launched by RBC Global Asset Management?
The newly launched ETFs include the RBC U.S. Mid-Cap Growth Equity Fund (RUMG) and the RBC Life Science and Technology Fund (RLST).
Where can I trade the new RBC GAM ETFs?
These ETFs can be traded on Cboe Canada and are accessible through both discount brokers and full-service dealers.
What is the investment strategy for the RBC U.S. Mid-Cap Growth Equity Fund?
This fund seeks long-term capital appreciation by primarily investing in mid-capitalized U.S. listed equities across diverse industries.
Who manages the RBC GAM ETFs?
The management of the RBC GAM ETFs is handled by RBC Global Asset Management Inc., which operates under the Royal Bank of Canada.
Why are these ETF launches significant?
These launches provide Canadian investors with varied access to U.S. markets and sectors that are crucial for future growth, especially in biotech and technology industries.
